On June 28, 2022, Clarivate Analytics released the latest Journal Citation Reports (JCR 2021). Journal of Translational Internal Medicine (JTIM) increased the impact factor to 3.772. It is ranked 62nd (172 journals) in the global MEDICINE, GENERAL & INTERNAL discipline, and ranked in Q2.

JTIM, launched in Dec 2013, is an open access journal publishing articles in all areas of translational internal medicine. The journal focuses on information derived from human disease-related experimentations so as to optimize the communication between basic scientific research and clinical science. It has a cycling nature, namely from basic research to clinical practice and then from clinical practice back to basic research.

JTIM has the ambition to and will become the EXCELLENT international platform for the publication of outstanding studies from all over the world. JTIM is designed to report research progress and the most recent findings in Translational Internal Medicine field, accelerating successful transformation from basic research results to clinically practical theories，diagnosis and treatment techniques, methodologies and drug discovery. With the aims of health care delivery and policy making, JTIM will help to best balance benefits, qualities and costs of medications. At JTIM, we have a challenging mission: to improve the quality of human life and enable people live longer by facilitating disease prevention, treatment and eventually the CURE. Articles published by JTIM can be accessed and downloaded at: https://sciendo.com/journal/JTIM.